It is found that a variety of tumors, including renal cell cancer (RCC), melanoma (MEL), as well as stomach, breast, ovarian, pancreatic, and lung cancers, express PD-L1, potentially contributing to immune suppression and evasion (Zou and Chen, 2008). This evidence concerns the gene CD274 and renal cell adenocarcinoma.